CDEK
← All drugs Report issue

jmt103

mAbexperimental

Clinical trial activity

9 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
6
Phase 3
3
Phase 4
0

Earliest trial started May 21, 2018 (NCT03550508)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06302465N/AMay 1, 2024Peking University
NCT06221072Phase 3Apr 5, 2024Shanghai JMT-Bio Inc.
NCT06314698Phase 3Apr 1, 2024Jiao Tong University, Shanghai JMT-Bio Inc.
NCT05813665Phase 3Apr 30, 2023Shanghai JMT-Bio Inc.
NCT05397938Phase 2Jun 15, 2022Shanghai JMT-Bio Inc.
NCT05278338Phase 2Apr 21, 2022Chinese Academy of Medical Sciences, Shanghai JMT-Bio Inc.
NCT04630522Phase 1Oct 31, 2020Huazhong University of Science and Technology, Shanghai JMT-Bio Inc.
NCT04198480Phase 1/Phase 2 (Phase 2)Jan 24, 2020Huazhong University of Science and Technology, Shanghai JMT-Bio Inc., Shijiazhuang Pharma Group (CSPC)
NCT03550508Phase 1May 21, 2018Covance, Huazhong University of Science and Technology, IQVIA, KingMed Diagnostics, Shanghai JMT-Bio Inc.
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shanghai JMT-Bio Inc.For profit8732018
Huazhong University of Science and TechnologyAcademic/Hospital3022018
Chinese Academy of Medical SciencesAcademic/Hospital1012022
CovanceFor profit1012018
IQVIAFor profit1012018
Jiao Tong UniversityAcademic/Hospital1112024
KingMed DiagnosticsFor profit1012018
Peking UniversityAcademic/Hospital1112024
Shijiazhuang Pharma Group (CSPC)For profit1012020
9 organizations
Page 1 / 1